Xiaonan Qiu

568 total citations
34 papers, 403 citations indexed

About

Xiaonan Qiu is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Xiaonan Qiu has authored 34 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Biomedical Engineering and 9 papers in Immunology. Recurrent topics in Xiaonan Qiu's work include Nanoplatforms for cancer theranostics (9 papers), Advanced Nanomaterials in Catalysis (5 papers) and Immunotherapy and Immune Responses (3 papers). Xiaonan Qiu is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Advanced Nanomaterials in Catalysis (5 papers) and Immunotherapy and Immune Responses (3 papers). Xiaonan Qiu collaborates with scholars based in China, United States and South Korea. Xiaonan Qiu's co-authors include Meilin Wang, Haiyan Chu, Na Tong, F. Du, Mengyu Yang, Xiuting Liu, Guoquan Tao, Qinghong Zhao, Miaomiao Zhang and Mulong Du and has published in prestigious journals such as PLoS ONE, Cancer and The FASEB Journal.

In The Last Decade

Xiaonan Qiu

31 papers receiving 398 citations

Peers

Xiaonan Qiu
Xiaonan Qiu
Citations per year, relative to Xiaonan Qiu Xiaonan Qiu (= 1×) peers Saeideh Jafarinejad‐Farsangi

Countries citing papers authored by Xiaonan Qiu

Since Specialization
Citations

This map shows the geographic impact of Xiaonan Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaonan Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaonan Qiu more than expected).

Fields of papers citing papers by Xiaonan Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaonan Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaonan Qiu. The network helps show where Xiaonan Qiu may publish in the future.

Co-authorship network of co-authors of Xiaonan Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaonan Qiu. A scholar is included among the top collaborators of Xiaonan Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaonan Qiu. Xiaonan Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, F., Lixia Xu, Yu Wang, et al.. (2025). Fe-Doped Carbon Dots-Incorporated In Situ Hydrogel for Near Infrared-Triggered Cascading Photothermal/Thermodynamic Therapy to Boost Cancer Immunity Cycle. Biomacromolecules. 26(4). 2601–2613. 1 indexed citations
2.
Yu, Huijun, Xiao Li Xu, Xiaonan Qiu, et al.. (2025). Prussian-Blue-Functionalized Polypyrrole Nanozyme via PTEN Activation and Hypoxia Reversal for Enhanced Photothermal Therapy of Tumor. ACS Biomaterials Science & Engineering. 11(7). 4453–4467. 1 indexed citations
3.
Wang, Qinxin, Feifei Wu, Xiaonan Qiu, et al.. (2025). Zinc phthalocyanine and sulfasalazine coloaded nanoaggregates with Prussian blue functionalization for sensitizing tumor photothermal/photodynamic therapy. Journal of Colloid and Interface Science. 685. 509–521. 2 indexed citations
4.
Zhang, Qiuyue, Kai Zhou, Wen Dong, et al.. (2025). Associations between the triglyceride–glucose index and the risk of heart failure in patients undergoing maintenance hemodialysis: a retrospective cohort study. Frontiers in Endocrinology. 16. 1544591–1544591. 2 indexed citations
5.
Fang, Zhengzou, Zhihui Yan, Chao Yan, et al.. (2024). Polydopamine nanoparticles cross-linked hyaluronic acid photothermal hydrogel with cascading immunoinducible effects for in situ antitumor vaccination. International Journal of Biological Macromolecules. 269(Pt 2). 132177–132177. 15 indexed citations
7.
Zhang, Yupeng, Jiaying Liu, Xiaonan Qiu, et al.. (2024). Fe-coordinated carbon dots with single atom nanozyme catalytic activity for synergistic catalytic/chemo-therapy in breast cancer. International Journal of Biological Macromolecules. 283(Pt 4). 137776–137776. 3 indexed citations
8.
Zhang, Shiqing, Mengyu Yang, Xiaonan Qiu, et al.. (2023). Bimetallic infinite coordination nanopolymers via phototherapy and STING activation for eliciting robust antitumor immunity. Journal of Colloid and Interface Science. 642. 691–704. 12 indexed citations
9.
Zhang, Lirong, Mengyu Yang, Beibei Yu, et al.. (2023). Mitochondrial-Targeted Gold-Doped Porous Carbon Nanodots for Combined Photothermal and Photodynamic Therapy of Breast Cancer. ACS Applied Nano Materials. 6(8). 7000–7010. 15 indexed citations
10.
Zhang, Miaomiao, Huijun Yu, Mengyu Yang, et al.. (2023). Immunoinducible Carbon Dot-Incorporated Hydrogels as a Photothermal-Derived Antigen Depot to Trigger a Robust Antitumor Immune Response. ACS Applied Materials & Interfaces. 15(6). 7700–7712. 42 indexed citations
11.
Qiu, Xiaonan, Zhenrui Shi, Si‐Yao Lu, et al.. (2023). TNF-α promotes CXCL-1/8 production in keratinocytes by downregulating galectin-3 through NF-κB and hsa-miR-27a-3p pathway to contribute psoriasis development. Immunopharmacology and Immunotoxicology. 45(6). 692–700. 5 indexed citations
12.
Liu, Xiuting, Zhenrui Shi, Si‐Yao Lu, et al.. (2022). Enhanced Migratory Ability of Neutrophils Toward Epidermis Contributes to the Development of Psoriasis via Crosstalk With Keratinocytes by Releasing IL-17A. Frontiers in Immunology. 13. 817040–817040. 17 indexed citations
13.
Shi, Zhenrui, Yuping Zhang, Xiaonan Qiu, et al.. (2022). Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1β in systemic lupus erythematosus. International Immunopharmacology. 112. 109197–109197. 4 indexed citations
14.
Qiu, Xiaonan, Lin Zheng, Xiuting Liu, et al.. (2021). ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils. Frontiers in Immunology. 12. 714274–714274. 19 indexed citations
15.
Wang, Xiaofang, et al.. (2021). The Correlation Between Tuberous Sclerosis Complex Genotype and Renal Angiomyolipoma Phenotype. Frontiers in Genetics. 11. 575750–575750. 11 indexed citations
16.
Zhang, Rui, Jie Shi, Xiaonan Qiu, et al.. (2020). Apigetrin ameliorates streptozotocin-induced pancreatic β-cell damages via attenuating endoplasmic reticulum stress. In Vitro Cellular & Developmental Biology - Animal. 56(8). 622–634. 12 indexed citations
17.
18.
Ge, Yuqiu, Hanting Liu, Xiaonan Qiu, et al.. (2018). Genetic variants in PI3K/Akt/mTOR pathway genes contribute to gastric cancer risk. Gene. 670. 130–135. 15 indexed citations
19.
Qiu, Xiaonan, Laura E. Pascal, Qiong Song, et al.. (2017). Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion. Neoplasia. 19(3). 207–215. 14 indexed citations
20.
Qiu, Xiaonan, Haixia Zhu, Sang Liu, et al.. (2016). Expression and prognostic value of microRNA‐26a and microRNA‐148a in gastric cancer. Journal of Gastroenterology and Hepatology. 32(4). 819–827. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026